Evidence map›Paper›PMID 39148835›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Personalized Fluid Management in Patients with Sepsis and AKI: A Policy Tree Approach.

Wonsuk Oh, Kullaya Takkavatakarn, Hannah Kittrell, Khaled Shawwa, Hernando Gomez, Ashwin S Sawant, Pranai Tandon, Gagan Kumar, Michael Sterling, Ira Hofer and 9 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Wonsuk Oh
Kullaya Takkavatakarn
Hannah Kittrell
Khaled Shawwa
Hernando Gomez
Pranai Tandon
Gagan Kumar
Michael Sterling
Ira Hofer
Lili Chan
John Oropello
Roopa Kohli-Seth
Alexander W CharneyORCID 0000-0001-8135-6858
Monica Kraft
Patricia Kovatch
John A Kellum
Girish N Nadkarni
Ankit Sakhuja

Funding

Incorporating genomics into the clinical care of diverse NYC childrenU01HG009610 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GELB, BRUCE D, HOROWITZ, CAROL R · 2017 to 2021
$17.0M
Multi-Omics and Chronic Kidney Disease: Correlation with HistologyR01DK108803 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Morgan Erika Grams, EUGENE P. RHEE · 2016 to 2026
$6.4M
Genomic Medicine Pilot For Hypertension And Kidney Disease In Primary CareU01HG007278 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HOROWITZ, CAROL R · 2013 to 2018
$5.7M
New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)TL1DK136048 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI JONATHAN M. BARASCH, Wadie F Bahou · 2022 to 2026
$3.8M
Mount Sinai Nephrology Research Training GrantT32DK007757 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CAMPBELL, KIRK N, HE, JOHN CIJIANG · 1998 to 2022
$3.8M
North East Consortium for Transplant outcomes in APOL1 kidney Recipients (NECTAR) Clinical CenterU01DK116100 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI Darshana Dadhania, Samira Farouk · 2017 to 2026
$2.5M
Using Novel Machine Learning Methods to Personalize Strategies for Prevention of Persistent AKI after Cardiac SurgeryK08DK131286 · NIDDK · WEST VIRGINIA UNIVERSITY · PI Ankit Sakhuja · 2022 to 2026
$774k
NHGRI NIH HHS U01 HG007278NHGRI NIH HHS U01 HG009610NIDDK NIH HHS K08 DK131286NIDDK NIH HHS R01 DK108803NIDDK NIH HHS T32 DK007757NIDDK NIH HHS TL1 DK136048NIDDK NIH HHS U01 DK116100
6 · The paper itself

Abstract

Rationale: Intravenous fluids are mainstay of management of acute kidney injury (AKI) after sepsis but can cause fluid overload. Recent literature shows that restrictive fluid strategy may be beneficial in some patients with AKI, however, identifying these patients is challenging. Objectives: We aimed to develop and validate a machine learning algorithm to identify patients who would benefit from a restrictive fluid strategy. Methods: We included patients with sepsis who developed AKI within 48 hours of ICU admission and defined restrictive fluid strategy as receiving <500mL fluids within 24 hours after AKI. Our primary outcome was early AKI reversal at 24 hours of AKI onset, and secondary outcomes included sustained AKI reversal and major adverse kidney events by 30 days (MAKE30). We used a causal forest, a machine learning algorithm to estimate individual treatment effects and policy tree algorithm to identify patients who would benefit by restrictive fluid strategy. We developed the algorithm in MIMIC-IV and validated it in SICdb databases. Measurements and Main Results: Among 2,044 patients in the external validation cohort, policy tree recommended restrictive fluids for 66.7%. Among these, patients who received restrictive fluids demonstrated significantly higher rate of early AKI reversal (47.1% vs 31.7%,p=0.004), sustained AKI reversal (28.7% vs 17.5%, p=0.013) and lower rates of MAKE30 (23.0% vs 37.1%, p=0.011). These results were consistent in adjusted analysis. Conclusion: Policy tree based on causal machine learning can identify septic patients with AKI who benefit from a restrictive fluid strategy. This approach needs to be validated in prospective trials.

Identifiers

PMID39148835
PMCPMC11326317

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.